“A Caffeic Acid Derivative Potential for Anticancer Drug: Synthesis of N-(piperidinyl)caffeamide and Its Activity against P388 Leukemia Murine Cells”, ICA, vol. 13, no. 2, pp. 38–42, Dec. 2020, doi: 10.70561/ica.v13i2.10962.